The timeline varies based on individual factors: baseline nutritional status, total weight loss speed, age, and genetic predisposition
By covalent (albiglutide, dulaglutide) or no-covalent (semaglutide) coupling to larger molecules with slow clearance, analogs with even more prolonged activity have been produced so that there are now several once-weekly agonists on the market
There's a lot of people who are under the impression that if you are not diabetic and you're using these Medications that you you're selfishly taking a drug away from a diabetic and I would love to hear your take on that McCall McPhereson: Yeah, you know, I think the majority of people who are on these medications for weight [00:36:00] loss, either from, you know, a BMI too high, prediabetes, you know, obesity or overweight, but with a complication of that, you know, of being overweight
Research shows a longer breastfeeding duration is associated with reduced maternal rates of type 2 diabetes and less postpartum weight retention
A randomised controlled trial of exenatide once-weekly in alcohol use disorder showed mixed results overall, with possible effects in certain subgroups
